全球阿片类 MU 受体激动剂市场 - 行业趋势及 2028 年预测

市场分析与洞察：全球阿片类 MU 受体激动剂市场

预计全球阿片类 MU 受体激动剂市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述研究预测期内，市场正以健康的复合年增长率增长。全球严重疼痛和药物成瘾患病率上升以及新兴市场是推动该市场增长的因素。

与疾病相关的剧烈疼痛病例不断增加，推动了全球阿片类 mu 受体激动剂市场的发展。不健康的生活方式和导致剧烈疼痛的疾病（如癌症、纤维肌痛和关节炎）增加了罹患疼痛的风险，这也促进了全球阿片类 mu 受体激动剂市场的增长。此外，治疗的普及也见证了这个市场的增长。药物成瘾和剧烈疼痛的患病率增加，政府在民众中开展的宣传活动，这些都推动了全球阿片类 mu 受体激动剂市场的发展。然而，大量的药物滥用死亡案例和 FDA 对含阿片类药物制造和销售的具体指导方针可能会阻碍全球阿片类 mu 受体激动剂市场的增长。

阿片类 mu 受体激动剂被认为是最有效的镇痛剂。它们通过首先与大脑中的 Mu 受体部位结合，然后与脊髓背角结合，产生镇痛作用。它们可用于低剂量的各种疼痛管理。尽管如此，它们也有一些缺点，例如奖励/欣快感、镇静、呼吸抑制、呕吐、恶心等，这将限制阿片类疼痛治疗。

This opioid MU receptor agonist market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Opioid MU Receptor Agonist Market Scope and Market Size

The opioid MU receptor agonist market is segmented on the basis of application, drugs, route of administration, end users, distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of application, the opioid MU receptor agonist market is segmented into pain management, cough management, diarrhea suppression, anesthesia, de-addiction and others.
• On the basis of drugs, the opioid MU receptor agonist market is segmented into IR/short acting, ER/long acting and others.
• On the basis of route of administration, the opioid MU receptor agonist market is segmented into oral, parenteral and others.
• On the basis of end users, the opioid MU receptor agonist market is segmented into hospitals, specialty clinics and others.
• On the basis of distribution channel, the opioid MU receptor agonist market has also been segmented into hospital pharmacy, retail pharmacy others.

Opioid MU Receptor Agonist Market Country Level Analysis

Global opioid MU receptor agonist market is analyzed and market size information is provided by country, application, drugs, route of administration, end users and distribution channel as referenced above.

The countries covered in the opioid mu receptor agonist market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America dominates the market share due to increasing healthcare and R&D expenditure, patient awareness and global players on novel technology or formulation of existing drugs plays major role for the growth of opioid mu receptor agonist market. Asia-Pacific is expected to account for the largest market share over coming years for the opioid mu receptor agonist market due to high prevalence cases diabetes and related disorders and number of generic drugs while, Europe is considered to hold bright growth prospects in the coming years by expanding the expenditure on the healthcare sector.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

This opioid MU receptor agonist market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Opioid MU Receptor Agonist Market Share Analysis

Global opioid MU receptor agonist market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to opioid MU receptor agonist market.

目前在阿片类 MU 受体激动剂市场工作的市场竞争对手包括 US WorldMeds, LLC. Hikma Pharmaceuticals PLC、ALLERGAN、Piramal Critical Care、DAIICHI SANKYO COMPANY, LIMITED.、SPECGX LLC、Janssen Pharmaceuticals, Inc.、Teva Pharmaceutical Industries Ltd.、Pfizer Inc.、Mylan NV、Purdue Pharma LP、WraSer LLC.、Lannett、Virtus、Sentynl Therapeutics, Inc.、Sun Pharmaceutical Industries Ltd.、Cipher Pharmaceuticals Inc. 以及其他国内和全球参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

SKU-60380